IMMUNOQUEST THERAPEUTICS AS
Operating
Forskning og utvikling av kreftbehandling.
Organization
- Chairman of the board
- HS
- Years since formation
- 3 years
- since Aug 15, 2023
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 30,000
- 1 share class
- Total number of shareholders
- 3
- 2 companies, 1 person
- Belongs to group of
Financials
- Annual total result 2024
- -751,504
- NOK
- Total equity 2024
- -721,496
- NOK
Last update: Feb 13, 2026
Locations
- Company addressGaustadalléen 21 0349 OSLO, NorgeCopied!
Management
Board
| Name | Role | Shares |
|---|---|---|
HS | Chairman | - |
VG | Board Member | - |
KE | Alternate Member | - |
MH | Board Member | - |
AP | Board Member | - |
KG 1964 | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
JA 1972 | - | 20 % directly |
SE | - | 20 % indirectly |
Last update: Feb 3, 2026
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 18,000 | 60 % | |
| Ordinary shares | 6,000 | 20 % | |
JA 1972 | Ordinary shares | 6,000 | 20 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2024: NOK 83,852,000Operating profit 2024: NOK -26,817,000Employees: 33
Financials
in NOK
Summary
| Year | 2024 | 2023 |
|---|---|---|
Total operating income | 0 | 0 |
Annual Total Result | -751,504 | 3 |
Total assets | 437,652 | 30,000 |
Total liabilities | 1,159,148 | 0 |
Total equity | -721,496 | 30,000 |
P&L
| Year | 2024 | 2023 |
|---|---|---|
Total operating income | 0 | 0 |
Total operating costs | 718,009 | 0 |
Operating result | -718,009 | 0 |
Financial income/costs | -33,496 | 3 |
Profit before tax | -751,504 | 3 |
Total tax & extraordinary income/cost | 0 | 0 |
Annual Total Result | -751,504 | 3 |
Balance overview
| Year | 2024 | 2023 |
|---|---|---|
Total fixed assets | 31,000 | 0 |
Total current assets | 406,652 | 30,000 |
Total assets | 437,652 | 30,000 |
Short term debt | 125,315 | 0 |
Long term debt | 1,033,833 | 0 |
Total liabilities | 1,159,148 | 0 |
Contributed capital | 30,000 | 30,000 |
Retained earnings | -751,496 | 0 |
Total equity | -721,496 | 30,000 |
Total equity and liabilities | 437,652 | 30,000 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
1120
Public incorporated enterprises, owned by central government